Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes
Abstract Background In a considerable number of patients with a suspected hereditary tumor syndrome (HTS), no underlying germline mutation is detected in the most likely affected genes. The present study aimed to establish and validate a large gene panel for HTS, and determine its diagnostic yield a...
Main Authors: | Jonas Henn, Isabel Spier, Ronja S. Adam, Stefanie Holzapfel, Siegfried Uhlhaas, Katrin Kayser, Guido Plotz, Sophia Peters, Stefan Aretz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Hereditary Cancer in Clinical Practice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13053-018-0102-4 |
Similar Items
-
Analytical Performance of NGS-Based Molecular Genetic Tests Used in the Diagnostic Workflow of Pheochromocytoma/Paraganglioma
by: Balazs Sarkadi, et al.
Published: (2021-08-01) -
Rare Hereditary Gynecological Cancer Syndromes
by: Takafumi Watanabe, et al.
Published: (2022-01-01) -
Diagnostic Strategies and Algorithms for Investigating Cancer Predisposition Syndromes in Children Presenting with Malignancy
by: Linda Rossini, et al.
Published: (2022-07-01) -
A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection
by: Carolina Velázquez, et al.
Published: (2020-06-01) -
Challenges and perspectives of the risk assessment of genetic susceptibility to cancer in the next-generation sequencing era.
by: Israel eGomy
Published: (2016-06-01)